Kevin Humphrey Faces Unexpected Diagnosis: Stage IV Lung Cancer

Endurance athlete and family man, Kevin Humphrey, was no stranger to pushing his physical limits. He regularly took on the demanding challenges of ultramarathons and similar feats. While accustomed to fatigue from training and keeping up with his two sons, an unrelenting backache began plaguing him in January 2024.

This discomfort soon escalated when Kevin started coughing, originally dismissed as pneumonia, but the coughing persisted despite treatment. A subsequent chest scan revealed an anomaly in his left lung. Although an initial biopsy offered inconclusive results, Kevin remained determined to find the cause of his symptoms.

A Shocking Discovery

In pursuit of clarity, Kevin traveled from Michigan to Chicago in May 2024 for further evaluation at Northwestern Medicine. A bronchoscopy there uncovered a devastating reality: a tumor was present in his lung, pressing against his airway and causing his symptoms.

Kevin, a non-smoker with no personal or familial history of lung cancer, was taken aback by the diagnosis. 'Lung cancer wasn't even a consideration for me,' he shared.

A Grave Diagnosis

The results were grim: Stage IV non-small cell lung cancer. The cancer had already metastasized, implying it had been developing for approximately a year. Statistically, the five-year survival rate for such a stage is about 37%.

Initially deemed inoperable due to its size, the tumor was later found to possess a driver mutation. 'These mutations often appear in younger, non-smokers,' explained Dr. Jonathan Villena-Vargas, a specialist not directly involved in Kevin’s treatment.

This discovery offered a new path. 'The mutation allowed us to use targeted therapies to turn around a seemingly dire situation,' said Kevin's oncologist, Dr. Daniel Dammrich. An aggressive treatment plan combining immunotherapy and chemotherapy was initiated, aiming to shrink the tumor to a surgically manageable size.

Facing Surgery and Uncertainty

Kevin's upcoming surgery posed significant questions about his future in endurance sports, as it involved removing about half of his left lung. The uncertainty of whether he would return to his physical pursuits loomed heavily.

Undeterred, Kevin set his sights on a new goal: the Ironman 70.3 race scheduled for just over a year post-surgery. He registered for the event with resolve, unsure but hopeful of his recovery.

September's surgery was a success, primarily removing the cancerous mass. The physical toll was severe, putting basic mobility and tasks beyond Kevin’s reach temporarily. Yet, recovery saw gradual improvement, each step fueled by his determination to participate in the Ironman.

Race Day and Reflection

On September 14, Kevin completed the Ironman alongside over 1,600 competitors, clocking in just under five and a half hours. The moment was filled with introspection, reflecting on the challenging journey he had traversed over the past year.

'Crossing that finish line was remarkably emotional,' Kevin recalled. 'I thought about my family and community support—none of this seemed feasible when I was diagnosed.'

Kevin's latest check-ups indicate positive outcomes: no current evidence of cancer remains. Vigilant surveillance through CT scans and blood tests ensures any recurrence is swiftly identified.

Continuing to challenge his endurance, Kevin participated in the Chicago marathon a month later, completing it for the sixth time, albeit at a slower pace. 'Simply finishing felt like a triumph,' he expressed.